Mark J. Murray
Direttore/Membro del Consiglio presso Genevant Sciences Corp.
Posizioni attive di Mark J. Murray
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Mark J. Murray
Precedenti posizioni note di Mark J. Murray
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Direttore/Membro del Consiglio | 14/10/2011 | 24/06/2019 |
| Amministratore Delegato | 30/05/2008 | 24/06/2019 | |
| Presidente | 30/05/2008 | 24/06/2019 | |
Protiva Biotherapeutics, Inc.
 Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Amministratore Delegato | 01/09/2000 | 02/12/2008 |
| Fondatore | 02/12/2008 | 02/12/2008 | |
| Presidente | - | 02/12/2008 |
Formazione di Mark J. Murray
| Oregon Health & Science University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Canada | 3 |
Posizioni
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| President | 2 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| Aziende private | 2 |
|---|---|
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Health Technology |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Health Technology |
- Borsa valori
- Insiders
- Mark J. Murray
- Esperienza
